Users Online: 1230
Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 

    Article Cited by others

HEAD AND NECK CANCER: ORIGINAL ARTICLE

A tertiary care experience with paclitaxel and cetuximab as palliative chemotherapy in platinum sensitive and nonsensitive in head and neck cancers

Noronha Vanita, Patil Vijay M, Joshi Amit, Bhattacharjee Atanu, Paul Davinder, Dhumal Sachin, Juvekar Shashikant, Arya Supreeta, Prabhash Kumar

Year : 2017| Volume: 6| Issue : 1 | Page no: 11-14

   This article has been cited by
 
1 Current Prospects of Molecular Therapeutics in Head and Neck Squamous Cell Carcinoma
K. Devaraja
Pharmaceutical Medicine. 2019; 33(4): 269
[Pubmed]  [Google Scholar] [DOI]
2 A comparison of weekly paclitaxel and cetuximab with the EXTREME regimen in the treatment of recurrent/metastatic squamous cell head and neck carcinoma
Kenji Nakano,Shoko Marshall,Shinichiro Taira,Yukiko Sato,Junichi Tomomatsu,Toru Sasaki,Wataru Shimbashi,Hirofumi Fukushima,Hiroyuki Yonekawa,Hiroki Mitani,Kazuyoshi Kawabata,Shunji Takahashi
Oral Oncology. 2017; 73: 21
[Pubmed]  [Google Scholar] [DOI]

 

Read this article